Dossier
investment restrictions
Coverage of investment restrictions in the Nexus archive.
- East Asia’s biotech autonomy push is already stunting innovation
The US-China technology rivalry is expanding into biotechnology, with export controls and investment restrictions creating a new strategic competition front. East Asia's push for biotech autonomy risks slowing innovation, highlighted by a 2025 US restriction on China's access to advanced biotechnology equipment.